{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:17:32Z","timestamp":1794003452011,"version":"4.8.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"No funding was received for this study"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11011-021-00684-w","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T03:38:23Z","timestamp":1612928303000},"page":"571-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Creatine attenuates seizure severity, anxiety and depressive-like behaviors in pentylenetetrazole kindled mice"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4057-3789","authenticated-orcid":false,"given":"Emmanuel O.","family":"Okwuofu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbenga E.","family":"Ogundepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail M.","family":"Akhigbemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinpelu L.","family":"Abiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond I.","family":"Ozolua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ighodaro","family":"Igbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ononiwu","family":"Chinazamoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"684_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126","journal-title":"Methods Enzymol"},{"key":"684_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11011-019-0390-z","volume":"34","author":"AM Akhigbemen","year":"2019","unstructured":"Akhigbemen AM, Ozolua RI, Bafor EE, Okwuofu EO (2019) Evaluation of some neuropharmacological effects of Caladium bicolor aiton (araceae) leaf extracts in mice. Metab Brain Dis 34:537\u2013544","journal-title":"Metab Brain Dis"},{"key":"684_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.biopha.2018.10.066","volume":"109","author":"GS Alana","year":"2019","unstructured":"Alana GS, Adriano JC1, Denia JVSO, Lopesa AA, Michele IS et al (2019) Prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide: Involvement of brain antioxidant and BDNF upregulating properties. Biomed Pharmacother 109:429\u2013439","journal-title":"Biomed Pharmacother"},{"key":"684_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.brainresbull.2008.02.035","volume":"76","author":"RH Andres","year":"2008","unstructured":"Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR (2008) Functions and effects of creatine in the central nervous system. Brain Res Bull 76:329\u2013343","journal-title":"Brain Res Bull"},{"key":"684_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205\u2013214","journal-title":"Nat Rev Drug Discov"},{"key":"684_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S0006-8993(00)03045-6","volume":"888","author":"AS Bazyan","year":"2001","unstructured":"Bazyan AS, Zhulin VV, Karpova MN, Klishina NY, Glebov RN (2001) Long- term reduction of benzodiazepine receptor density in the rat cerebellum by acute seizures and kindling and its recovery 6 months later by a pentylenetetrazole challenge. Brain Res 888:212\u2013220","journal-title":"Brain Res"},{"issue":"5","key":"684_CR7","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00726-011-0851-0","volume":"40","author":"MF Beal","year":"2011","unstructured":"Beal MF (2011) Neuroprotective effects of creatine. Amino Acids 40(5):1305\u20131313","journal-title":"Amino Acids"},{"key":"684_CR8","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.neurobiolaging.2007.03.001","volume":"29","author":"A Bender","year":"2008","unstructured":"Bender A, Beckers J, Schneider I, Holter SM, Haack T, Ruthsatz T et al (2008) Creatine improves health and survival of mice. Neurobiol Aging 29:1404\u20131411","journal-title":"Neurobiol Aging"},{"key":"684_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnhum.2013.00624","volume":"7","author":"BC Bernhardt","year":"2013","unstructured":"Bernhardt BC, Hong S, Bernasconi A, Bernasconi N (2013) Imaging structural and functional brain networks in temporal lobe epilepsy. Front Hum Neurosci 7:53\u201366","journal-title":"Front Hum Neurosci"},{"issue":"2","key":"684_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/BF02148042","volume":"19","author":"E Beutler","year":"1963","unstructured":"Beutler E, Kelly BM (1963) The effect of sodium nitrite on red cell GSH. Experientia 19(2):96\u201397","journal-title":"Experientia"},{"key":"684_CR11","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s43440-020-00143-w","volume":"72","author":"KK Borowicz-Reutt","year":"2020","unstructured":"Borowicz-Reutt KK, Czuczwar SJ (2020) Role of oxidative stress in epileptogenesis and potential implications for therapy. Pharmacol Rep 72:1218\u20131226","journal-title":"Pharmacol Rep"},{"issue":"2","key":"684_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4161\/oxim.2.2.7944","volume":"2","author":"J Bouayed","year":"2009","unstructured":"Bouayed J, Rammal H, Soulimani R (2009) Oxidative stress and anxiety: relationship and cellular pathways. Oxid Med Cell Longev 2(2):63\u201367","journal-title":"Oxid Med Cell Longev"},{"key":"684_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10863-010-9317-4","volume":"42","author":"SJ Chang","year":"2010","unstructured":"Chang SJ, Yu BC (2010) Mitochondrial matters of the brain: mitochondrial dysfunction and oxidative status in epilepsy. J Bioenerg Biomembr 42:457\u2013459","journal-title":"J Bioenerg Biomembr"},{"key":"684_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1046\/j.1600-0404.2003.00151.x","volume":"108","author":"S Choi-Kwon","year":"2003","unstructured":"Choi-Kwon S, Chung C, Kim H, Lee S, Yoon S et al (2003) Factors affecting the quality of life in patients with epilepsy in Seoul, South Korea. Acta Neurol Scand 108:428\u2013434","journal-title":"Acta Neurol Scand"},{"key":"684_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2013.02.012","volume":"704","author":"KM Choudhary","year":"2013","unstructured":"Choudhary KM, Mishra A, Poroikov VV, Goel RK (2013) Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. Eur J Pharmacol 704:33\u201340","journal-title":"Eur J Pharmacol"},{"key":"684_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.yebeh.2010.08.018","volume":"19","author":"S Cotterman-Hart","year":"2010","unstructured":"Cotterman-Hart S (2010) Depression in epilepsy: why aren\u2019t we treating? Epilepsy Behav 19:419\u2013421","journal-title":"Epilepsy Behav"},{"key":"684_CR17","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1177\/0269881112447989","volume":"26","author":"MP Cunha","year":"2012","unstructured":"Cunha MP, Machado DG, Capra JC, Jacinto J, Bettio LE, Rodrigues ALS (2012) Antidepressant-like effect of creatine in mice involves dopaminergic activation. J Psychopharmacol 26:1489\u20131501","journal-title":"J Psychopharmacol"},{"key":"684_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.brainresbull.2013.01.005","volume":"95","author":"MP Cunha","year":"2013","unstructured":"Cunha MP, Pazini FL, Oliveira A, Machado, Lucia SA (2013) Evidence for the involvement of 5-HT1A receptor in the acute antidepressant-like effect of creatine in mice. Brain Res Bull 95:61\u201369","journal-title":"Brain Res Bull"},{"key":"684_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1046\/j.1528-1157.2001.30800.x","volume":"42","author":"CL Deckers","year":"2001","unstructured":"Deckers CL, Hekster YA, Keyser A, van Lier HJ, Meinardi H, Renier WO (2001) Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study. Epilepsia 42:1387\u20131394","journal-title":"Epilepsia"},{"key":"684_CR20","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1074\/jbc.M710012200","volume":"283","author":"L Devi","year":"2008","unstructured":"Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283:9089\u20139100","journal-title":"J Biol Chem"},{"key":"684_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.niox.2011.02.002","volume":"24","author":"A Dhir","year":"2011","unstructured":"Dhir A, Kulkarni SK (2011) Nitric oxide and major depression. Nitric Oxide 24:125\u2013131","journal-title":"Nitric Oxide"},{"key":"684_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","volume":"28","author":"AS Elhwuegi","year":"2004","unstructured":"Elhwuegi AS (2004) Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 28:435\u2013451","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"684_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mrfmmm.2009.07.005","volume":"670","author":"C Fimognari","year":"2009","unstructured":"Fimognari C, Sestili P, Lenzi M, Cantelli-Forti G, Hrelia P (2009) Protective effect of creatine against RNA damage. Mutat Res 670:59\u201367","journal-title":"Mutat Res"},{"key":"684_CR24","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","volume":"45","author":"A Gaitatzis","year":"2004","unstructured":"Gaitatzis A, Carroll K, Majeed A, Sander W (2004) The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45:1613\u20131622","journal-title":"Epilepsia"},{"key":"684_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.yebeh.2008.05.006","volume":"13","author":"HR Griffith","year":"2008","unstructured":"Griffith HR, Martin R, Andrews S, LeBron Paige A, Ware J, Faught E et al (2008) The safety and tolerability of galantamine in patients with epilepsy and memory difficulties. Epilepsy Behav 13:376\u2013380","journal-title":"Epilepsy Behav"},{"key":"684_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0091-3057(02)01044-4","volume":"74","author":"YK Gupta","year":"2003","unstructured":"Gupta YK, VeerendraKumar MH, Srivastava AK (2003) Effect of Centella asiatica on pentylenetetrazole-induced kindling, cognition and oxidative stress in rats. Pharmacol Biochem Behav 74:579\u2013585","journal-title":"Pharmacol Biochem Behav"},{"key":"684_CR27","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1007\/s11064-010-0198-z","volume":"35","author":"R Hosamani","year":"2010","unstructured":"Hosamani R, Ramesh SR, Muralidhara (2010) Attenuation of rotenone-induced mitochondrial oxidative damage and neurotoxicty in drosophila melanogaster supplemented with creatine. Neurochem Res 35:1402\u20131412","journal-title":"Neurochem Res"},{"issue":"5","key":"684_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1211\/jpp.62.05.0008","volume":"62","author":"R Jayaraman","year":"2010","unstructured":"Jayaraman R, Manisenthil KT, Anitha T, Joshi VD, Palei NN, Gajera K, Ladani K (2010) Influence of etoricoxib on anticonvulsant activity of phenytoin and diazepam in experimental seizure models in mice. J Pharm Pharmacol 62(5):610\u2013614","journal-title":"J Pharm Pharmacol"},{"key":"684_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.yebeh.2005.07.014","volume":"7","author":"PC Jobe","year":"2005","unstructured":"Jobe PC, Browning RA (2005) The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav 7:602\u2013619","journal-title":"Epilepsy Behav"},{"key":"684_CR30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.0013-9580.2004.47003.x","volume":"45","author":"EK Johnson","year":"2004","unstructured":"Johnson EK, Jones JE, Seidenberg M, Hermann BP (2004) The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 45:544\u2013550","journal-title":"Epilepsia"},{"key":"684_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/WCO.0b013e3282f4e978","volume":"21","author":"AM Kanner","year":"2008","unstructured":"Kanner AM (2008) Depression in epilepsy: a complex relation with unexpected consequences. Curr Opin Neurol 21:190\u2013194","journal-title":"Curr Opin Neurol"},{"key":"684_CR32","doi-asserted-by":"crossref","unstructured":"Kanner AM (2014) Is depression associated with an increased risk of treatmentresistant epilepsy? Research strategies to investigate this question. Epilepsy Behav 38:3e7","DOI":"10.1016\/j.yebeh.2014.06.027"},{"key":"684_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/ebeh.2000.0030","volume":"1","author":"AM Kanner","year":"2000","unstructured":"Kanner AM, Palac S (2000) Depression in epilepsy: a common but often unrecognized comorbid malady. Epilepsy Behav 1:37\u201351","journal-title":"Epilepsy Behav"},{"key":"684_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.yebeh.2012.01.007","volume":"24","author":"AM Kanner","year":"2012","unstructured":"Kanner AM, Schachter SC, Barry JJ, Hersdorffer DC, Mula M, Trimble M et al (2012) Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav 24:156\u2013168","journal-title":"Epilepsy Behav"},{"key":"684_CR35","doi-asserted-by":"crossref","unstructured":"Kwon OY, Park SP (2014) Depression and anxiety in people with epilepsy [published correction appears in J Clin Neurol. 2014 Oct;10(4):375]. J Clin Neurol 10(3):175\u2013188","DOI":"10.3988\/jcn.2014.10.3.175"},{"key":"684_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0074-7742(08)00020-2","volume":"83","author":"WC LaFrance Jr","year":"2008","unstructured":"LaFrance WC Jr, Kanner AM, Hermann B (2008) Psychiatric comorbidities in epilepsy. Int Rev Neurobiol 83:347\u2013383","journal-title":"Int Rev Neurobiol"},{"key":"684_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/bbrc.2001.6164","volume":"290","author":"JM Lawler","year":"2002","unstructured":"Lawler JM, Barnes WS, Wu G, Song W, Demaree S (2002) Direct antioxidant properties of creatine. Biochem Biophys Res Commun 290:47\u201352","journal-title":"Biochem Biophys Res Commun"},{"key":"684_CR38","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.neuroscience.2007.03.026","volume":"147","author":"LP Liang","year":"2007","unstructured":"Liang LP, Beaudoin ME, Fritz MJ et al (2007) Kainate-induced seizures, oxidative stress and neuronal loss in aging rats. Neuroscience 147:1114\u20131118","journal-title":"Neuroscience"},{"key":"684_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.eplepsyres.2014.10.003","volume":"109","author":"G MacKenzie","year":"2015","unstructured":"MacKenzie G, Maguire J (2015) Chronic stress shifts the GABA reversal potential in the hippocampus and increases seizure susceptibility. Epilepsy Res 109:13\u201327","journal-title":"Epilepsy Res"},{"key":"684_CR40","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.brainres.2007.09.023","volume":"1185","author":"DV Magni","year":"2007","unstructured":"Magni DV, Oliveira MS, Furian AF, Fiorenza NG, Fighera MR, Ferreira F (2007) Creatine decreases convulsions and neurochemical alterations induced by glutaric acids in rats. Brain Research 1185:336\u2013345","journal-title":"Brain Research"},{"issue":"2","key":"684_CR41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuint.2007.06.005","volume":"52","author":"EB Malarkey","year":"2008","unstructured":"Malarkey EB, Parpura V (2008) Mechanism of glutamate release from astrocytes. Neurochem Int 52(2):142\u2013154","journal-title":"Neurochem Int"},{"issue":"7","key":"684_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a022798","volume":"6","author":"A Mazarati","year":"2016","unstructured":"Mazarati A, Sankar R (2016) Common mechanisms underlying epileptogenesis and the comorbidities of epilepsy. Cold Spring Harb Perspect Med 6(7):1\u201317","journal-title":"Cold Spring Harb Perspect Med"},{"key":"684_CR43","doi-asserted-by":"crossref","unstructured":"Mazarati A, Siddarth P, Baldwin RA, Shin D, Caplan R, Sankar R (2008) Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain 131(8):2071\u20132083","DOI":"10.1093\/brain\/awn117"},{"key":"684_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2019.00077","volume":"13","author":"M Mele","year":"2019","unstructured":"Mele M, Costa RO, Duarte CB (2019) Alterations in GABAA-receptor trafficking and synaptic dysfunction in brain disorders. Front Cell Neurosci 13:1\u201315","journal-title":"Front Cell Neurosci"},{"key":"684_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejphar.2011.11.010","volume":"674","author":"A Mishra","year":"2012","unstructured":"Mishra A, Goel RK (2012) Age dependent learning and memory deficit in Pentylenetetrazol kindled mice. Eur J Pharmacol 674:315\u2013320","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"684_CR46","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","volume":"247","author":"HP Misra","year":"1972","unstructured":"Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247(10):3170\u20133175","journal-title":"J Biol Chem"},{"issue":"6","key":"684_CR47","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.bcp.2004.12.001","volume":"69","author":"M Murias","year":"2005","unstructured":"Murias M, Jager W, Handler N, Erker T, Horvath Z, Szekeres T, Nohl H, Gille L (2005) Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structureactivity relationship. Biochem Pharmacol 69(6):903\u2013912","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"684_CR48","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1017\/S1461145707008401","volume":"11","author":"F Ng","year":"2008","unstructured":"Ng F, Berk M, Dean O, Bush AI (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11(6):851\u2013876","journal-title":"Int J Neuropsychopharmacol"},{"key":"684_CR49","unstructured":"NIH (2015) Public health service policy on humane care and use of laboratory animals. http:\/\/grants.nih.gov\/grants\/olaw\/references\/PHSPolicyLabAnimals.pdf. Accessed 17 March 2020"},{"key":"684_CR50","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","journal-title":"Anal Biochem"},{"key":"684_CR51","first-page":"397","volume":"153","author":"N Paciello","year":"2002","unstructured":"Paciello N, Mazza M, Mazza S (2002) Depression in epilepsy: symptoms or syndrome? Clin. Ter 153:397\u2013402","journal-title":"Ter"},{"key":"684_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yebeh.2003.10.013","volume":"5","author":"MK Pavlova","year":"2004","unstructured":"Pavlova MK, Shea SA, Bromfield EB (2004) Day\/night patterns of focal seizures. Epil Behav 5:44\u201349","journal-title":"Epil Behav"},{"key":"684_CR53","doi-asserted-by":"crossref","unstructured":"Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525\u2013529","DOI":"10.1016\/0091-3057(86)90552-6"},{"key":"684_CR54","doi-asserted-by":"publisher","first-page":"551","DOI":"10.4103\/0253-7613.165198","volume":"47","author":"SA Pimpalkhute","year":"2015","unstructured":"Pimpalkhute SA, Bajait CS, Dakhale GN, Sontakke SD, Jaiswal KM, Kinge P (2015) Assessment of quality of life in epilepsy patients receiving anti-epileptic drugs in a tertiary care teaching hospital. Indian J Pharmacol 47:551\u2013554","journal-title":"Indian J Pharmacol"},{"key":"684_CR55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuint.2009.04.007","volume":"55","author":"LM Rambo","year":"2009","unstructured":"Rambo LM, Ribeiro LR, Oliveira MS, Furian AF, Lima FD, Souza MA et al (2009) Additive anticonvulsant effects of creatine supplementation and physical exercise against pentylenetetrazol-induced seizures. Neurochem Int 55:333\u2013340","journal-title":"Neurochem Int"},{"key":"684_CR56","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.bbi.2008.06.005","volume":"22","author":"H Rammal","year":"2008","unstructured":"Rammal H, Bouayed J, Younos C, Soulimani R (2008) Evidence that oxidative stress is linked to anxiety-related behaviour in mice. Brain Behav Immun 22:1156\u20131159","journal-title":"Brain Behav Immun"},{"issue":"1","key":"684_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.eplepsyres.2004.10.001","volume":"63","author":"M Sayyah","year":"2005","unstructured":"Sayyah M, Yousefi-Pour M, Narenjkar J (2005) Anti-epileptogenic effect of beta-carotene and vitamin A in pentylenetetrazole-kindling model of epilepsy in mice. Epilepsy Res 63(1):11\u201316","journal-title":"Epilepsy Res"},{"key":"684_CR58","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.freeradbiomed.2005.10.035","volume":"40","author":"P Sestili","year":"2006","unstructured":"Sestili P, Martinelli C, Bravi G, Piccoli G, Curci R, Battistelli M et al (2006) Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radic Biol Med 40:837\u2013849","journal-title":"Free Radic Biol Med"},{"key":"684_CR59","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/mnfr.200800504","volume":"53","author":"P Sestili","year":"2009","unstructured":"Sestili P, Barbieri E, Martinelli C, Battistelli M, Guescini M, Vallorani L et al (2009) Creatine supplementation prevents the inhibition of myogenic differentiation in oxidatively injured C2C12 murine myoblasts. Mol Nutr Food Res 53:1187\u20131204","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"684_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1358\/mf.2010.32.4.1452090","volume":"32","author":"B SharmaV, Nehru","year":"2010","unstructured":"SharmaV, Nehru B, Munshi A, Jyothy A (2010) Antioxidant potential of curcumin against oxidative insult induced by pentylenetetrazol in epileptic rats. Methods Find Exp Clin Pharmacol 32(4):227\u2013232","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"684_CR61","volume-title":".. The causes of epilepsy","year":"2011","unstructured":"Shorvon SD, Andermann F, Guerrini R (eds) (2011) .. The causes of epilepsy. Cambridge University Press, Cambridge"},{"key":"684_CR62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejphar.2016.05.019","volume":"784","author":"T Singh","year":"2016","unstructured":"Singh T, Goel RK (2016) Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression. Eur J Pharmacol 784:111\u2013120","journal-title":"Eur J Pharmacol"},{"key":"684_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuint.2016.12.023","volume":"104","author":"T Singh","year":"2017","unstructured":"Singh T, Kaur T, Goel RT (2017) Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression. Neurochem Int 104:27\u201333 ()","journal-title":"Neurochem Int"},{"key":"684_CR64","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) Tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"684_CR65","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1528-1167.2006.00458.x","volume":"47","author":"WH Theodore","year":"2006","unstructured":"Theodore WH, Giovacchini G, Bonwetsch R, Bagic A, Reeves-Tyer P, Herscovitch P et al (2006) The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography. Epilepsia 47:499\u2013503","journal-title":"Epilepsia"},{"key":"684_CR66","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ana.410200202","volume":"20","author":"Y Yaari","year":"1986","unstructured":"Yaari Y, Selzer ME, Pincus JH (1986) Phenytoin: mechanism of its anticonvulsive action. Ann Neurol 20:171\u2013184","journal-title":"Ann Neurol"},{"issue":"9","key":"684_CR67","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.psyneuen.2010.03.010","volume":"35","author":"S Yager","year":"2010","unstructured":"Yager S, Forlenza MJ, Miller GE (2010) Depression and oxidative damage to lipids. Psychoneuroendocrinology. 35(9):1356\u20131362","journal-title":"Psychoneuroendocrinology."},{"issue":"1","key":"684_CR68","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.brainres.2006.04.093","volume":"1099","author":"M Yildirim","year":"2006","unstructured":"Yildirim M, Marangoz C (2006) Anticonvulsant effects of melatonin on penicillin-induced epileptiform activity in rats. Brain Res 1099(1):183\u2013188","journal-title":"Brain Res"},{"key":"684_CR69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/JBCPP.2000.11.1.73","volume":"11","author":"A Yuksel","year":"2000","unstructured":"Yuksel A, Cengiz M, Seven M, Ulutin T (2000) Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy. J Basic Clin Physiol Pharmacol 11:73\u201381","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"684_CR70","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fnbeh.2017.00203","volume":"11","author":"X Zhu","year":"2017","unstructured":"Zhu X, Han JB, Zhang RA, Xia Z, Chang H, Chao J, Yao H (2017) Neuronal nitric oxide synthase contributes to PTZ kindling-induced cognitive impairment and depressive-like behavior. Front Behav Neurosci 11:203\u2013215","journal-title":"Front Behav Neurosci"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00684-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-021-00684-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00684-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:22:03Z","timestamp":1724455323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-021-00684-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1007\/s11011-021-00684-w","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,9]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author did not declare any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained for this study with number \u2013 EC\/FP\/19\/25.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}